News | May 06, 2024
Tatva Chintan Pharma Chem posts Q4 FY24 PAT at Rs. 9.61 Cr
The company has posted net profit of Rs.30.35 crores for the Financial Year ended March 31, 2024
The company has posted net profit of Rs.30.35 crores for the Financial Year ended March 31, 2024
Glenmark’s Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg (OTC), will be distributed in the U.S. by Glenmark Therapeutics, USA
The QC Lab is equipped with advanced instruments to ensure rigorous quality control across all manufacturing processes
The joint venture will help JV Partners combine their strengths and grow their complementary nutraceuticals portfolios
Laurus Labs has reported total income of Rs. 1,458.20 crores during the period ended March 31, 2024
Approval from Colombia's INVIMA will accelerate growth in Colombia, by registering our product and getting regular supplies
NULIBRY is a first-in-class synthetic cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A
The campaign marks an important milestone in its journey within the pharmaceutical manufacturing industry
The US Generics market has been witnessing significant pricing pressure leading to significant losses at Jubilant Cadista since FY2022 onwards.
10th edition of the event is scheduled to be held during May 30-June 1 at Hitex, Hyderabad
Subscribe To Our Newsletter & Stay Updated
